Fri, 11 Oct 2019 02:41:46 GMT
EU's BioNtech shares rise 10% in US market debut
Shares in the European biotech firm BioNtech jumped 10% to $16.69 in their market debut held on Thursday, after the German company downsized its IPO and priced the stock below the range expected earlier, valuing BioNtech at $3.78B.